Cargando…
Cyclical Combination Chemotherapy in Advanced Breast Cancer
Results with cyclical combination chemotherapy in advanced breast cancer are presented. The overall remission rate, 79 per cent, is superior to that obtained by two conventional endocrine procedures, administration of norethisterone acetate and hypophysectomy. The advantage is especially pronounced...
Autores principales: | Edelstyn, G. A., Macrae, K. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1973
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008915/ https://www.ncbi.nlm.nih.gov/pubmed/4758373 |
Ejemplares similares
-
Thiotepa in the treatment of advanced breast cancer.
por: Lyons, A. R., et al.
Publicado: (1965) -
Thyroid Hormone as a Prophylactic Agent Following Radical Treatment of Breast Cancer
por: Lyons, A. R., et al.
Publicado: (1965) -
Neoadjuvant chemotherapy in combination with surgery in the treatment of local advanced breast cancer
por: Zhao, Haixia, et al.
Publicado: (2019) -
Pertuzumab in Combination with Trastuzumab and Chemotherapy in the Treatment of HER2-Positive Metastatic Breast Cancer: Safety, Efficacy, and Progression Free Survival
por: Maly, Joseph J, et al.
Publicado: (2014) -
Chemotherapy of advanced breast cancer: outcome and prognostic factors.
por: Gregory, W. M., et al.
Publicado: (1993)